A detailed history of Prudent Investors Network, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Prudent Investors Network, Inc. holds 5,918 shares of ABT stock, worth $696,252. This represents 0.21% of its overall portfolio holdings.

Number of Shares
5,918
Previous 5,918 -0.0%
Holding current value
$696,252
Previous $614,000 9.77%
% of portfolio
0.21%
Previous 0.22%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$100.73 - $112.44 $25,988 - $29,009
-258 Reduced 4.18%
5,918 $614,000
Q1 2024

May 16, 2024

BUY
$109.52 - $120.96 $3,723 - $4,112
34 Added 0.55%
6,176 $701,000
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $2,101 - $2,521
22 Added 0.36%
6,142 $594,000
Q2 2023

Jul 18, 2023

SELL
$100.78 - $112.29 $4,434 - $4,940
-44 Reduced 0.71%
6,120 $667,000
Q1 2023

May 17, 2023

SELL
$96.86 - $114.01 $16,853 - $19,837
-174 Reduced 2.75%
6,164 $624,000
Q2 2022

Sep 14, 2022

SELL
$102.07 - $123.37 $3,572 - $4,317
-35 Reduced 0.55%
6,338 $689,000
Q1 2022

May 06, 2022

SELL
$114.02 - $139.04 $22,804 - $27,808
-200 Reduced 3.04%
6,373 $754,000
Q4 2021

Feb 09, 2022

SELL
$115.53 - $141.46 $9,242 - $11,316
-80 Reduced 1.2%
6,573 $925,000
Q2 2021

Jul 26, 2021

BUY
$105.79 - $124.53 $4,443 - $5,230
42 Added 0.64%
6,653 $771,000
Q1 2021

Apr 29, 2021

BUY
$108.84 - $128.23 $44,950 - $52,958
413 Added 6.66%
6,611 $792,000
Q4 2020

Jan 28, 2021

SELL
$105.0 - $114.42 $12,915 - $14,073
-123 Reduced 1.95%
6,198 $678,000
Q3 2020

Nov 03, 2020

BUY
$91.64 - $111.29 $4,123 - $5,008
45 Added 0.72%
6,321 $687,000
Q2 2020

Aug 11, 2020

SELL
$76.57 - $98.0 $2,833 - $3,626
-37 Reduced 0.59%
6,276 $573,000
Q1 2020

Apr 08, 2020

BUY
$62.82 - $91.86 $2,324 - $3,398
37 Added 0.59%
6,313 $498,000
Q4 2019

Jan 30, 2020

BUY
$78.51 - $87.4 $492,728 - $548,522
6,276 New
6,276 $545,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Prudent Investors Network, Inc. Portfolio

Follow Prudent Investors Network, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudent Investors Network, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Prudent Investors Network, Inc. with notifications on news.